Harvey M. Golomb to Clinical Trials as Topic
This is a "connection" page, showing publications Harvey M. Golomb has written about Clinical Trials as Topic.
Connection Strength
0.108
-
Concomitant chemoradiotherapy for non-small cell lung cancer. Lung Cancer. 1994 Mar; 10 Suppl 1:S253-61.
Score: 0.019
-
Hairy cell leukaemia. Baillieres Clin Haematol. 1993 Dec; 6(4):887-98.
Score: 0.019
-
Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia. J Natl Cancer Inst. 1988 May 04; 80(5):369-73.
Score: 0.013
-
Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients. J Clin Oncol. 1986 Jun; 4(6):900-5.
Score: 0.011
-
Chemotherapy of metastatic non-small cell bronchogenic carcinoma. Semin Oncol. 1983 Mar; 10(1):111-22.
Score: 0.009
-
Banding studies of chromosomal abnormalities in patients with acute lymphocytic leukemia. Cancer Res. 1979 Jan; 39(1):227-38.
Score: 0.007
-
Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. Cancer Treat Rep. 1978 Apr; 62(4):567-9.
Score: 0.006
-
Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma. Cancer Treat Rep. 1978 Mar; 62(3):327-32.
Score: 0.006
-
A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung. Semin Oncol. 1998 Feb; 25(1 Suppl 2):8-14.
Score: 0.006
-
Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables. J Clin Oncol. 1988 Nov; 6(11):1714-21.
Score: 0.003
-
Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experience. Cancer. 1984 Jul 01; 54(1):5-12.
Score: 0.002
-
Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy. Eur J Cancer Clin Oncol. 1983 Jan; 19(1):33-8.
Score: 0.002
-
Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment. Cancer. 1979 Jul; 44(1):72-9.
Score: 0.002